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Omega-alkynylErythrocyte lipid rafts are anchored to the underlying spectrin membrane skeleton [A. Ciana, C. Achilli,
C. Balduini, G. Minetti, On the association of lipid rafts to the spectrin skeleton in human erythrocytes,
Biochim. Biophys. Acta 1808 (2011) 183–190]. The nature of this linkage and the molecules involved are
poorly understood. The interaction is sensitive to the increase in pH and ionic strength induced by carbonate.
Given the role of palmitoylation in modulating the partitioning of certain proteins between various
sub-cellular compartments and the plasma membrane, we asked whether palmitoylation of p55, a peripheral
protein located at the junctional complex between spectrin-actin-protein 4.1 that anchors the membrane
skeleton to the lipid bilayer via the transmembrane protein glycophorin C, could contribute to the anchoring
of lipid rafts to the membrane skeleton. We adopted a new, non-radioactive method for studying protein
palmitoylation, based on bio-orthogonal chemical analogues of fatty acids, containing an omega-alkynyl
group, to metabolically label cell proteins, which are then revealed by a “click chemistry” reaction of the
alkynyl moiety with an azide-containing reporter tag. We show that the membrane localization and
palmitoylation levels of p55 did not change after carbonate treatment. 2-bromopalmitate and cerulenin, two
known palmitoylation inhibitors, completely inhibited p55 palmitoylation, and protein palmitoyl thioesterase-1
(PPT1) reduced it, without affecting the association between lipid rafts and membrane-skeleton, indicating, on
the one hand, that p55 palmitoylation is enzymatic, and, on the other, that it is not involved in the modulation
of the linkage of lipid rafts to the membrane-skeleton.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Lipid rafts are membrane nano-micro-domains enriched in
sphingolipids and cholesterol in liquid ordered state, and selected classes
of proteins, such as GPI-anchored, signal transducing and other acylated
proteins [1]. The biochemical characterization of lipid rafts has histori-
cally been based on their isolation as Detergent-Resistant-Membranes
(DRMs), which are portions of the membrane insoluble in non-ionic
detergents, such as Triton X-100 (TX100), at low temperatures [2].
We have shown previously that, differently fromwhat observed in
other cell types, erythrocyte DRMs, with the properties of canonicalP, 2-bromopalmitic acid; DFP,
membranes; GPC, glycophorin
l thioesterase 1; TX100, Triton
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l rights reserved.lipid rafts, where lipids are in liquid-ordered state and speciﬁc marker
proteins are enriched [3], are tightly anchored to the spectrin mem-
brane skeleton. The incubation with the detergent alone is not sufﬁ-
cient to allow the isolation of DRMs as a band of low density in
sucrose gradients, unless a simultaneous increase in pH and ionic
strength is induced, for instance by using a carbonate salt [4].
The molecules involved in the linkage between erythrocyte DRMs
and the membrane skeleton are not known. The connection appears
not to involve the two main vertical linkages, mediated by ankyrin
and protein 4.1, which anchor the spectrin skeleton to the integral
membrane proteins band 3 and glycophorin C (GPC), respectively.
These proteins are in fact excluded from the raft compartment [5].
The requirement for carbonate in the protocol for their isolation
would indicate that lipid rafts are anchored by an electrostatic mech-
anism. This may involve the lipid raft marker protein stomatin (alone
or together with stomatin-like-protein-2) [6,7], which has been
found in relatively large amounts in erythrocyte lipid rafts [8], or a
direct binding of membrane phospholipids to spectrin [9,10].
It is also conceivable that palmitoylated proteins in the mem-
brane, such as p55 (also known as membrane palmitoylated protein
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itself [15], could be responsible for the anchoring of lipid rafts. If this
were the case, the mechanism of action of carbonate in releasing the
lipid rafts from the membrane skeleton could be related, rather than
to the perturbation of electrostatic interactions, to the hydrolysis, in
the alkaline environment generated by carbonate itself, of the relatively
weak thioester bond that links palmitic acid to the protein.
There is increasing evidence for a role of protein lipidation in the
process of protein sorting [16] and in modulating the partitioning
of proteins into the sphingolipid rich domains of the membrane
[17]. In particular, protein S-palmitoylation has been shown to be a
means of reversibly regulating the targeting of membrane proteins
to lipid rafts [18]. The study of protein palmitoylation has been generally
affected by the limitations in the assay methods. Original evidence
of S-palmitoylation of erythrocyte proteins, in particular of p55, was
obtained after metabolic labeling of erythrocytes with tritium-labeled
palmitate, protein separation by electrophoresis, and days-long autora-
diography. Recent developments havemade available novel approaches
for the study of protein fatty-acylation [19–24]. One of these is based on
chemical analogues of fatty acids containing an alkynyl group in the
omega position of the hydrocarbon chain, which have been demon-
strated to be bio-orthogonal, i.e. to behave as the unmodiﬁed, natural
compound, in being metabolically incorporated by the cells into the
target proteins, and to undergo a chemical reaction without cross reac-
tivity with biochemical processes. Following the incorporation of the
analogue, this is made to react with an azide-containing reporter tag
that could be then visualized via ﬂuorescence or chemiluminescence
approaches.
We have explored the palmitoylation turnover in erythrocytemem-
brane proteins by this newmethod. The localization and palmitoylation
level of p55 have been thus investigated in the presence and in the
absence of carbonate, and after incubation with inhibitors of protein
palmitoylation, in search for a possible role of p55 palmitoylation in
the anchoring of lipid rafts to the membrane skeleton.
2. Materials and methods
2.1. Materials
ω-alkynyl palmitic acid (Alk-C16) and biotin-azide were synthe-
sized as described earlier [19] and supplied by Genentech, South
San Francisco, California, USA; Tris(2-carboxyethyl)phosphine hydro-
chloride (TCEP) (code C4706), Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)
methyl]amine (TBTA) (code 678937), 2-Bromopalmitic acid (code
21604), cerulenin (code C2389), di-isopropylﬂuorophosphate (DFP),
Na-pyruvate (code P8574), Coenzyme A (code C3019), penicillin G
and horseradish peroxidase (HRP)-conjugated avidin (code A7419)
were from Sigma-Aldrich. Goat polyclonal (N-19) anti-human p55
(code sc-13490), mouse monoclonal (BRIC10) anti-human GPC
(code sc-59183) and HRP-conjugated mouse anti-goat IgG (code
sc-2354) were from Santa Cruz Biotechnology. Mouse polyclonal
anti-human protein 4.1 (code H00002035-A01) was from Abnova.
HRP-conjugated goat anti-mouse IgG (code 170-6516), PVDF mem-
branes 0.2 μm pore diameter (code 162-0177), and protein molecular
weight standards (Precision Plus Protein™ Standards All Blue, code
161-0373; Prestained SDS-PAGE Standards Low Range, code 161-0305;
SDS-PAGE Standards Broad Range, code 161-0317), were from Bio-Rad
Laboratories.
2.2. Blood processing
Blood was freshly collected from healthy human donors in ACD-B
(Vacuette®, Greiner bio-one) or in 0.1 vol of 3.8% (w/v) sodium citrate
as anticoagulants. Erythrocytes were puriﬁed from leukocytes and
platelets by ﬁltration on a mixture made of equal parts, by weight,
of α-cellulose and microcrystalline cellulose equilibrated with PBS(5 mM Na-phosphate, 154.5 mM NaCl, 4.5 mM KCl, pH 7.4) [25].
Filtered cells were washed three times with PBS before use.
2.3. Metabolic labeling of cellular proteins with Alk-C16
Puriﬁed erythrocytes were incubated at 10% hematocrit at 37 °C
for 16–18 h under gentle end-over-end agitation, with 20–25 μM
Alk-C16 (stock solution 50 mM in DMSO), or 0.05% (v/v) DMSO, in
the following buffer: 40 mM imidazole, 90 mM NaCl, 5 mM KCl,
5 mM MgCl2, 0.5 mM EGTA, 15 mM glucose, 30 mM sucrose, 5 mM
Na-pyruvate, 5 μM Coenzyme A, 200 U/ml penicillin G, pH 7.6, 300–
320 mosmol/kg H2O [26]. After incubation, erythrocytes were washed
once in cold PBS, treated with 3.5 mM (ﬁnal concentration) DFP in PBS
for 10 min, washed with PBS containing 0.2% BSA to remove unbound
Alk-C16 and ﬁnally with PBS. Cells were next lysed with hypotonic
buffer (5 mM Na-phosphate, pH 8) according to Dodge [27], but with-
out EDTA, in order to avoid chelation of copper ions during the subse-
quent cycloaddition reaction (see below), and washed until white
ghost membranes were obtained. The volume of the ghost suspension
was adjusted to that of the original sample of packed erythrocytes,
resulting in a protein concentration of approximately 5 mg/ml in the
ghost suspension.
2.4. Alkyne-azide cycloaddition reaction (click chemistry)
Freshly prepared ghostswereﬁrst dilutedwith one vol of hypotonic
buffer, then to 21 μl of this diluted sample the following reagents were
added, from concentrate stock solutions, and in the exact order given,
for the Cu(I)-catalysed (3+2) Huisgen cycloaddition reaction or click
reaction (ﬁnal concentrations): SDS (0.5%), biotin-azide (0.1 mM),
TCEP (1 mM) (to generate Cu+ in situ from the reduction of Cu2+),
TBTA (0.2 mM) (to complex Cu+ and allow the regio-selective cyclo-
addition), CuSO4 (1 mM) [19]. The ﬁnal volume was 25 μl, containing
approximately 50 μg of membrane proteins. Higher sample concentra-
tion (4–5 μg proteins/μl) resulted in a weaker signal after Western
blotting and chemiluminescence detection (see below). After 1 h at
room temperature the samples were diluted with one vol of PBS,
mixed with 0.5 vol of reducing SDS-PAGE sample buffer [50 mM
Tris–HCl pH 6.8, 5% (w/v) SDS, 5 mM EDTA, 200 mM DTT, 35% (w/v)
sucrose, 0.01% bromophenol blue], heated at 60 °C for 15 min and
loaded (6–20 μg proteins/lane) on 5–15% (w/v) linear polyacrylamide
gradient SDS-PAGE gels [28] for electrophoresis and Western blotting
(see below).
2.5. Preparation of DRMs and processing of sucrose gradient fractions
DRMs were extracted from whole erythrocytes as previously
described [5]. Brieﬂy, ﬁltered, DFP-treated erythrocytes (1.25×109)
were diluted in TX100-containing HKM buffer (5 mM HEPES,
150 mM KCl, 4.5 mM NaCl, 2 mM MgCl2, pH 7.4), so that the ﬁnal
volume was 0.625 ml and the ﬁnal detergent concentration 1% (w/v).
Samples were incubated on ice for 30 min, mixed with an equal vol
of 80% (w/v) sucrose in HKM or in 0.3 MK2CO3, transferred to ultracen-
trifuge tubes (5 ml, Ultra-clear™, code N. 344057, Beckman Coulter),
layered with 2.5 ml of 30% sucrose and 1.25 ml of 5% sucrose solutions
in HKM, and spun at 225,000×gmax at 4 °C in a bench-top ultracen-
trifuge (Optima-Max, equipped with a swinging-arm MLS50 rotor,
Beckman Coulter). After ultracentrifugation, DRMs ﬂoating at the
interface 5–30% sucrose solutions were collected in 1 ml fraction,
while the 40% sucrose, Hb-rich bottom of the gradient was split and
collected in four 0.34 ml fractions. Proteins in the fractions were
analysed by SDS-PAGE in 10% (w/v) isocratic or 5–15% (w/v) linear
gradient polyacrylamide gels. The DRM fraction was mixed with 0.5
vol of reducing SDS-PAGE sample buffer, while the bottom fractions
were dissolved in 9 vol of dilute SDS-PAGE sample buffer [1 vol of re-
ducing SDS-PAGE sample buffer plus 1.7 vol of 5% (w/v) SDS in water],
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chemiluminescence detection. Alternatively, samples were processed
as follows for SDS-PAGE and Coomassie staining: bottom fractions
were heated in 3 vol of dilute SDS-PAGE sample buffer and proteins
separated by SDS-PAGE. Gels were stained with 0.2% (w/v) Coomassie
blue R250 in 20% (w/v) trichloroacetic acid (TCA) and destained with
7.5% (v/v) acetic acid.
For detecting the palmitoylation of proteins contained in the
bottom fraction of the gradient, white ghost membranes, not whole
erythrocytes, had to be subjected to TX100 treatment, because of Hb
interference with the click chemistry. Ghosts were puriﬁed from
Alk-C16-labeled erythrocytes (1.25×109) and incubated in ﬁnal 1%
TX100 in PKM (5 mM Na-phosphate, 150 mM KCl, 4.5 mM NaCl,
2 mM MgCl2, pH 7.4) at 4 °C for 30 min. Samples were mixed with
an equal vol of 80% sucrose in 0.2 M K2CO3 and ultracentrifuged in
sucrose density gradients in PKM for 1 h as described above. The
bottom 40% sucrose step of the gradient was subjected to the click
reaction after dilution 1:10 in 5 mM Na-phosphate and subsequent
concentration to one tenth of the original volume in a Centricon
centrifugal ﬁlter device, cut-off 3000 Da (Millipore). This dialysis
step was required to remove sucrose, carbonate, and K+ (which
induces the precipitation of the SDS used in the click reaction).
2.6. Incubation of erythrocytes with inhibitors of protein palmitoylation:
2-bromopalmitic acid (2BP) and cerulenin
Erythrocytes were incubated at 10% hematocrit at 37 °C for 4 h
with or without 50 μM 2BP or 200 and 400 μM cerulenin, added
from stock solutions of, respectively, 100 mM and 90 mM concentra-
tion in DMSO. After incubation with 2BP, cells were washed three
times in the incubation buffer without 2BP, before adding Alk-C16
and metabolic labeling as described above. After incubation with
cerulenin, cells were either washed free of the inhibitor or not, before
adding Alk-C16 and metabolic labeling as described above. Ghost
membranes were puriﬁed from the labeled erythrocytes and subjected
to the click chemistry reaction as described above.
2.7. Incubation of ghost membranes with palmitoyl-protein
thioesterase-1 (PPT1)
Recombinant PPT1 was a kind gift from Prof. Sandra L. Hofmann,
University of Texas Southwestern Medical Center, Dallas, Texas, USA
[29]. Ghost membranes puriﬁed from Alk-C16-labeled erythrocytes,
pre-diluted with one vol of hypotonic buffer, were incubated at 37 °C
for 1 h in the presence of 0.05 μg/μl PPT1 at pH 8, and then subjected
to the click chemistry reaction and Western blotting detection as
described above.
2.8. Western blotting and chemiluminescence detection
Following SDS-PAGE, proteins were electro-transferred to PVDF
membranes [30]. For detection of biotin-labeled proteins, PVDF mem-
branes were incubated overnight at 4 °C in blocking buffer [20 mM
Tris-HCl pH 7.4, 150 mM NaCl, 0.05% (v/v) Tween-20, 5% (w/v)
skimmed milk], then washed three times (5 min each) with PBS
containing 0.1% Tween-20, incubated with horseradish-peroxidase-
conjugated avidin 1:10,000 for 1 h at 25 °C and developed using
chemiluminescence detection reagent Amersham™ ECL plus Western
blotting detection system (GE Healthcare).
The same membranes, after at least 1 h at 25 °C incubation with
0.02% NaN3 in washing buffer [50 mM Tris-HCl pH 7.5, 0.2 M NaCl,
1% (w/v) polyethylene glycol 20000, 1% (w/v) BSA, 0.5% (v/v)
Tween-20], were re-probed for p55 detection. For detection of
proteins with speciﬁc antibodies, PVDF membranes were dipped for
1 h at 25 °C in blocking buffer, then overnight at 4 °C in the primary
antibody (goat anti-p55 diluted 1:200, mouse anti-GPC diluted 1:4000andmouse anti-protein 4.1 diluted 1:2000) inwashing buffer. Secondary
antibodieswere diluted inwashing buffer (mouse anti-goat 1:4000, goat
anti-mouse 1:10,000 and goat anti-mouse 1:4000, respectively) and
added for 1 h at 25 °C after PVDF membranes were properly washed in
the same solution. Finally, proteins were revealed with the Amersham
detection reagent.
For palmitoylation experiments, that palmitate was actually
bound to proteins via a thioester bond was assessed by evaluating
the sensitivity of the acylation to hydroxylamine, a reagent which
speciﬁcally removes fatty acid incorporated into proteins via thioester
but not amide linkage. After SDS-PAGE and Western blotting, PVDF
membranes were soaked for 72 h at room temperature in 5% (w/v)
hydroxylamine (NH2OH) in PBS containing 0.1% Tween-20, and then
subjected to chemiluminescence detection.3. Results
3.1. Development of the Alk-C16 labeling protocol in human erythrocytes
First, it was necessary to verify that the ω-alkynyl analogue of
palmitic acid was bio-orthogonally incorporated into acyl-modiﬁed
proteins also in the erythrocyte model. Our initial hope was that
the cycloaddition reaction required for the linking of the ω-alkynyl
moiety to the detection probe (biotin-azide in our case) could be
conducted on a whole cell lysate. However, it became immediately
clear that this could not be done, as the presence of even trace
amounts of Hb strongly inhibited the reaction. Therefore, following
metabolic labeling by incubation at 10% hematocrit with 20 μM
Alk-C16 for 16 h at 37 °C [12], erythrocytes were processed for prep-
aration of ghost membranes by hypotonic hemolysis. Only highly
puriﬁed ghost membrane preparation, i.e. ghost membranes that
were carefully washed free of Hb (Fig. 1A, “white gh.”), could be suc-
cessfully subjected to the cycloaddition reaction, whereas “pink
ghost” membranes showed no signal (Fig. 1A, “pink gh.”). With this
procedure an intense band of approximately 55 kDa was visible,
together with other, less intense bands, in the samples incubated
with Alk-C16 (Fig. 1A, top panel, “Alk-C16 white gh.”). Apart from
several other minor bands, whose identity deserves further analysis,
at least the 55 kDa palmitoylation signal was sensitive to treatment
with hydroxylamine, indicative of the analogue being metabolically
incorporated via a thioester bond into this protein (Fig. 1B, top
panel). Re-probing of the two membranes with anti-p55 conﬁrmed
that the most intensely palmitoylated band was indeed p55 (Fig. 1A,
bottom panel), and that the hydroxylamine treatment is really effec-
tive in only cleaving the thioester bond without affecting the amount
of p55 on the blotting membrane (Fig. 1B, bottom panel). Moreover,
the identity of p55 with the 55 kDa palmitoylated band was con-
ﬁrmed by immunoprecipitation of p55 with the sc-13490 antibody
(not shown).
As the conventional protocols for ghost preparation contemplate
the use of EDTA, which is a strong inhibitor of the cycloaddition reac-
tion because it chelates the required copper ions, special care had to
be taken to avoid EDTA in all the buffers (not shown). Although the
original protocol contemplated the use of a non-ionic detergent
(0.9% TX100) in the sample-processing buffer prior to the cycloaddi-
tion reaction, we observed that the inclusion of 0.5% SDS together
with the non-ionic detergent strongly improved the signal (not shown).
As a further improvement to the protocol, it was observed that an ad-
ditional one-fold dilution of the “white” ghost membranes to be
subjected to the cycloaddition reaction signiﬁcantly improved the
subsequent signal response (Fig. 1C and D, compare “undil.” vs. “dil.”
ghosts), probably because of additional dilution of traces of contami-
nating Hb. As a result of the above described optimization procedures,
the sensitivity of the method was greatly increased: less than 20 μg
total ghost proteins were loaded in each lane.
Fig. 1. Detection of erythrocyte membrane palmitoylated proteins by Alk-C16 metabolic labeling and click chemistry. Erythrocytes were metabolically labeled as described in
Materials and methods. (A, B) Two parallel PVDF membranes from gels that were loaded with ghosts prepared from labeled cells by hypotonic hemolysis and repeated washings
in hypotonic buffer until membranes turned white (“white gh.”); “pink gh.” refers to partially washed ghosts, not completely free of Hb. Alk-C16 labeled membrane proteins were
revealed by click chemistry reaction of the alkynyl moiety with biotin-azide, followed by SDS-PAGE and Western blotting. (C, D) Two parallel PVDF membranes from gels loaded
with white ghosts (prepared from labeled cells) were subjected to the click chemistry reaction without (“undil. gh.”, protein concentration 4–5 μg/ml) or with pre-dilution 1:1 in
buffer (“dil. gh.”, protein concentration 2 μg/ml), then to SDS-PAGE and Western blotting. Top panels: chemiluminescence detection with HRP-conjugated avidin without (A, C) or
with (B, D) pre-incubation of the blotting membranes in hydroxylamine. Hydroxylamine-treated membranes were purposely overexposed to better show the differential in the
hydroxylamine-sensitive signals. Arrows indicate palmitoylated protein p55. Bottom panels: Immunodetection with anti-p55 antibody of the membranes shown in the top panels.
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after DRM extraction
Protein p55 is believed to be localized at the junctional complex of
the membrane skeleton, where it associates on the one side with the
spectrin skeleton, via protein 4.1, and on the other with the integral
membrane protein GPC. However, little information exists on the par-
tition of p55 among the various fractions resulting from detergent
treatment of erythrocytes. We have recently shown that the lipid
raft fraction obtained under optimized conditions from whole eryth-
rocytes by TX100+carbonate treatment contains only trace amounts
of p55 [5]. In order to explore the possible role of p55 palmitoylation
in the linkage of lipid rafts to the membrane skeleton, we have
analysed the localization of p55 relative to spectrin and GPC, before
and after detaching lipid rafts from the membrane skeleton by
carbonate.
Puriﬁed, DFP-treated erythrocytes were incubated with 1% TX100
at 4 °C, mixed with 80% sucrose in buffer or in carbonate, and
subjected to ultracentrifugation for 16 h in sucrose density gradient
(Fig. 2A). After treatment with TX100 alone, the linkage between
lipid rafts and the membrane skeleton is preserved [5] (Fig. 2A, tube
1, fraction “a”). Protein p55 segregates together with GPC, protein
4.1 and spectrin in the high-density DRM material of the sucrose
gradient (Fig. 2A, bottom panels). Following addition of carbonate,
the lipid rafts detach from the membrane skeleton and ﬂoat at the
5–30% sucrose interface in the gradient (Fig. 2A, tube 2, arrow),
whereas p55 remains completely localized with GPC, protein 4.1
and spectrin in the dense fractions of the gradient (Fig. 2A, bottom
panels).
We then askedwhether the release of lipid rafts from themembrane
skeleton under the action of carbonate was related to depalmitoylation
of p55. For this experiment, erythrocytes were ﬁrst metabolically
labeled with Alk-C16. White ghosts were then prepared from these
cells and subjected to TX100 treatment with the addition of carbonate
and ultracentrifugation in sucrose gradient. The p55-containing bottom
of the tube was collected and subjected to the “click chemistry” reac-
tion as described in Materials and methods. As shown in Fig. 2B, the
p55 palmitoylation signal in the bottom of the gradient (Fig. 2B, lane
“bottom”) is quantitatively similar to that detected in the correspondingcontrol ghost sample (Fig. 2B, lane “Alk-C16+”). This indicates that the
p55 protein, which remains associated with the membrane skeleton,
and which amounts to the full complement of p55 molecules of the
cell, is also still fully palmitoylated even after carbonate treatment.
Therefore, carbonate, which is known to affect the linkage between
DRMs and the spectrin skeleton, does not so by cleaving the thioester
bond between p55 and its palmitic moiety.
3.3. p55 palmitoylation is inhibited by 2-bromopalmitate and cerulenin
To further investigate the role of p55 palmitoylation in anchoring
the lipid raft to themembrane skeleton,we adopted a different strategy,
consisting in inhibiting protein palmitoylation. To this purpose, we test-
ed two known pharmacological inhibitors of protein palmitoylation:
2-bromopalmitate (2BP), a non metabolizable palmitate analogue, and
cerulenin, a natural anti-fungal antibiotic.
Cells were incubatedwith the inhibitors for 4 h at 37 °C prior to the
metabolic labeling with Alk-C16. p55 palmitoylation was completely
prevented by 50 μM 2BP (Fig. 3A), or 200 μM cerulenin (Fig. 3B). 2BP
was irreversibly incorporated into the cell compartment, and the inhib-
itory effect persisted even when cells were washed before metabolic
labeling with Alk-C16. On the contrary, cerulenin had to be left in the
incubation medium, because washing of the cells before metabolic la-
beling resulted in the loss of the inhibitory effect on palmitoylation
(Fig. 3C).
That Alk-C16 was indeed linked via a thioester bond was shown
by the selective removal of the label following incubation of the puriﬁed
ghost membranes (derived from erythrocytes metabolically labeled
with Alk-C16), with recombinant PPT1, a lysosomal enzyme charac-
terized by insensitivity to serine-modifying reagents like DFP [29],
followed by the “click chemistry” reaction. As shown in Fig. 3D, this
resulted in a signiﬁcant decrease of p55 palmitoylation.
3.4. The p55 lipid moiety is not involved in anchoring lipid rafts to the
membrane skeleton
We further demonstrated that p55 palmitoylation is not responsi-
ble for the interaction between lipid rafts and the membrane skeleton
by using 2BP. Erythrocytes were subjected to metabolic labeling with
Fig. 2. Localization and palmitoylation state of p55 after isolation of lipid rafts. (A) Erythrocytes were treated with 1% Triton X-100 at 4 °C for 30 min, then mixed with 80% sucrose
in HKM buffer (tube 1) or in 0.3 M K2CO3 (tube 2) and ultracentrifuged for 16 h in sucrose gradients. DRMs were recovered only in the presence of carbonate as a low density band
ﬂoating at the interface 5–30% sucrose (arrow). The 40% sucrose bottoms of the gradients were collected in four fractions (a–d from tube 1; a'–d' from tube 2) from the top and
protein content in each fraction, and in the DRM fraction (“DRM”), were analysed by Western blotting (p55, GPC, protein 4.1) and Coomassie blue staining. (B) p55 palmitoylation
after carbonate treatment was assayed in the 40% sucrose fraction of a separate gradient, in which Alk-C16-labeled ghosts were loaded. Top panel: Palmitoylated proteins in ghost
samples puriﬁed from Alk-C16-unlabeled or Alk-C16-labeled erythrocytes, and in the gradient bottom fraction (“bottom”). The arrow indicates palmitoylated p55. Bottom panel:
Immunodetection of p55 in the membrane shown in the top panel.
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lysed in 1% TX100 at 4 °C and subjected to the ﬂotation experiment in
sucrose gradient without addition of carbonate. The effectiveness of
2BP in inhibiting palmitoylation was checked by parallel analysis of
a sample of puriﬁed white ghosts prepared from the treated cells.Fig. 3. Effect of protein palmitoylation inhibitors 2BP and cerulenin, and of PPT1 enzyme, on
50 μM2BP, washed, labeled with Alk-C16, and palmitoylated proteins detected by click react
cerulenin, then subjected to Alk-C16 labeling in the presence of the same concentration o
remove the unbound cerulenin before metabolic labeling, resulted in the loss of the inhib
palmitoylation was assayed on Alk-C16 labeled ghosts incubated with 0.05 μg/ml PPT1 at
A, B, D was revealed by re-probing the same blotting membranes with anti p55 antibody.The metabolic labeling with Alk-C16 itself does not interfere with
the recovery of DRMs as a band of low density material, as veriﬁed
by control samples treated with carbonate (Fig. 4, compare tubes 2
and 4). However, no low density DRM material was observed after
ultracentrifugation in the sucrose gradient of 2BP-treated cells inp55 palmitoylation. Top panels: (A) Erythrocytes were incubated at 37 °C for 4 h with
ion andWestern blotting. (B) Erythrocytes were incubated at 37 °C for 4 h with 200 μM
f cerulenin, followed by detection of palmitoylated proteins. (C) Washing the cells to
itory effect, even at higher (400 μM) inhibitor concentration. (D) PPT1 effect on p55
37 °C for 1 h. Bottom panels: the amount of p55 in the same samples shown in panels
Fig. 4. Effect of the inhibition of p55 palmitoylation on the association between lipid
rafts and the membrane skeleton. Control and Alk-C16-labeled erythrocytes were
treated with 1% TX100 at 4 °C for 30 min and ultracentrifuged in sucrose gradients
in the absence or in the presence of carbonate, as indicated. Pre-treatment of cells
with 2BP does not induce detachment of DRMs from the membrane skeleton (tube 5).
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ment of p55 palmitoylation in modulating the linkage between lipid
rafts and the membrane skeleton.4. Discussion
The study of protein lipidation has been classically hampered by tech-
nical difﬁculties connectedmostlywith the requirement for radio-labeled
compounds and time-consuming detection protocols. Recent technical
developments have made accessible a ﬂourishing number of new
molecular tools and novel chemistries for studying this type of post-
translational modiﬁcation of proteins [19–24]. Among the new tech-
niques, the one based on ω-alkynyl analogues of long-chain fatty acids
for studying protein fatty acylation looks promising, especially for inves-
tigating reversible cellular processes such as protein S-palmitoylation.
The bio-orthogonal ω-alkynyl analogue of palmitic acid is readily incor-
porated into proteins undergoing active palmitate turnover.
Two fundamentally different methods exist for studying protein
S-palmitoylation: one is based on the metabolic utilization of a suitable
palmitic acid probe, whether a radioactively-labeled [31] or bio-
orthogonal analogue [19], followed by separation and visualization
of the labeled protein. The second, exempliﬁed by the so called
acyl-biotin-exchange (ABE) method [22,32], consists in a series of
passages through which the naturally-occurring palmitic acid residue
bound to a given protein via a thioester bond is replaced by a chemical
probe that binds to the cysteine's thiol group originally linked to the
palmitic acid. While the ﬁrst method is only useable for proteins that
undergo active palmitate turnover in vivo, the second method can also
detect stably palmitoylated proteins, although its implementation
may be more difﬁcult, due to the several critical steps required for
processing the samples [32].
Be as it may, the new techniques may re-open old ﬁelds of study
that were abandoned because of the intrinsic limitations of the exper-
imental methodology. For instance, erythrocytes were among the ﬁrst
cell types where protein palmitoylation was studied [13,33–35]. It be-
came immediately clear that this cell type, which does not perform
protein synthesis, still retains the ability of reversibly palmitoylatinga number of proteins, in a way that is apparently regulated physiolog-
ically, because different proteins display a different rate of palmitate
incorporation and different rates of depalmitoylation, suggesting an
independent regulation of the turnover [36]. Ankyrin was the ﬁrst
protein to be shown to undergo reversible palmitoylation in avian
and rabbit erythrocytes [13,37] but, since human erythrocyte ankyrin
does not appear to be palmitoylated, those results were criticized
[26]. Other palmitoylated proteins identiﬁed to a reasonable degree
of certainty in the human erythrocytes are the Rh polypeptide [35],
a subpopulation of spectrin [12], the anion exchanger protein (AE1)
band 3 [38,39], although band 3 does not undergo palmitate turnover
to any appreciable extent, suggesting that itmay be stably palmitoylated,
and no biological role for this modiﬁcation has been demonstrated
[40,41], stomatin [15,42], protein 4.2 [14], and p55. Before its identiﬁ-
cation and characterization [11], p55was long known to be the protein
with the highest palmitate incorporation on metabolic labeling
[13,26,33,35], and at a certain time it was proposed that this protein
band coincided with the glucose transporter [43], which was subse-
quently proved wrong [44]. Although the exact disposition and func-
tion of p55 in the erythrocyte membrane are still not known [45,46],
subsequent characterization of this protein suggested a role for bridg-
ing themembrane skeleton to the bilayer by associationwith GPC [47],
in a ternary complex involving protein 4.1, p55 and GPC. p55 would
bind, with its PDZ domain, to the cytoplasmic tail of GPC, and, with a
central domain of 39 residues, to a region of the 30 kDa domain in pro-
tein 4.1 which also contains a binding site for GPC [48,49]. In a recent
article, one possible site for palmitoylation of p55 has been mapped at
Cys 242 [22]. Interestingly, only one palmitoylation site could be iden-
tiﬁed in this protein, which was sometimes deﬁned, in the older liter-
ature, as “multiply” or “heavily” palmitoylated [11,46,50]. Either the
latter were arbitrary deﬁnitions, originating from the relatively faster
palmitate turnover that this protein undergoes in erythrocytes, or
there exist in factmore than one palmitoylated cysteines in erythrocyte
p55, owing to the presence in this cell type of different palmitoylating
enzyme(s) with respect to the one(s) expressed in the cell type used
for the proteome-scale analysis of S-acylated proteins (see below)
[22]. It is interesting to note that, if conﬁrmed, the palmitoylated Cys
in p55 lies in the middle of the 39-residue domain that binds protein
4.1, suggesting a possible role for palmitoylation in modulating this
linkage and thus one of the vertical interactions of the spectrin skeleton
with the lipid bilayer.
The enzymatic machinery which maintains the palmitate turnover
on a selected subset of membrane proteins is not characterized in
erythrocytes. After the discovery in yeast of enzymes that catalyse
palmitoylation reactions (PATs, protein acyl transferases), the long
standing issue whether palmitoylation is a spontaneous [51] or
enzyme-mediated reaction appears to be solved in favour of the latter
hypothesis [52]. This research has culminated in the discovery of
approximately 23 genes in the human genome that encode
S-palmitoyltransferase proteins, belonging to the so called DHHC
family (from the consensus sequence Asp-His-His-Cys that the mem-
bers of this group have in common) [52–54]. Yet, apparently no
DHHC protein is expressed in human erythrocytes, based on a survey
of the most recent and accurate proteome analysis of this cell type
[55–60]. This is despite a report was published about the puriﬁcation
fromhuman erythrocytes of a protein-palmitoyl acyltransferase, whose
relation to the now characterized DHHC family remains to be examined
[61]. On the other hand, it is still possible that other palmitoyl transfer-
ases exist, that do not belong to the DHHC family [52].
Only recently, results have been published that claim that DHHC
17 is the isoform of PAT expressed in erythrocytes [62]. This ﬁnding
awaits future conﬁrmation. In fact, there is serious concern that those
data may be affected by a major ﬂaw, consisting in the contamination
by granulocytes of the erythrocyte preparations used by the Authors.
Published results of our recentwork on erythrocyteDRMs have unques-
tionably demonstrated that the isolation of lipid rafts as a low-density
930 A. Ciana et al. / Biochimica et Biophysica Acta 1828 (2013) 924–931fraction in sucrose gradients is only possible with the addition of car-
bonate to the detergent-containing medium [5]. The lipid raft fraction
isolated by the Authors was dislodged from the anchored membrane
skeleton thanks to the action of proteases released from contaminating
neutrophils. This contamination could also have affected the identiﬁ-
cation of DHHC 17 as the isoform expressed in erythrocytes. The evi-
dence presented in our work, and in that of Lach and collaborators,
on the effects of 2BP, together with our additional demonstration
that another inhibitor, cerulenin [63], is also effective in inhibiting
MPP1 palmitoylation, would support the enzymatic nature for the
mechanism of protein palmitoylation in the human erythrocyte. 2BP
has been shown to act as a strong, irreversible inhibitor of DHHCs in
vitro [64]. This could explain its higher effectiveness, with respect to
cerulenin, in blocking incorporation of Alk-C16 in erythrocytes. As
only one enantiomer of 2BP was shown to be effective in inhibiting
acyl-CoA synthetase [65] (which was also found expressed in
erythrocytes [66]), and probably other fatty-acid utilizing enzymes,
and because we used a commercial racemic version of 2BP, the
concentration of the effective inhibitor in our experiments was
25 μM. The mechanism of inhibitory action of cerulenin is not
understood. Evidence for a covalent modiﬁcation, by cerulenin, of
critical thiols in either the protein acceptor substrates or in the
palmitoyl acyl transferase has been reported [63]. However, this
proposed mechanism of action is difﬁcult to reconcile with the
results presented here, where cerulenin had to be present all
along the incubation with Alk-C16 to inhibit its incorporation
into proteins. It cannot be ruled out, on the other hand, that
chemical instability of cerulenin under the experimental conditions
described, was the cause of its loss of effectiveness upon washing.
Given the ease with which palmitoylation of erythrocyte proteins
can be studied using the click chemistry method, the erythrocyte
model could be successfully adopted for screening new inhibitors
of palmitoyl-transferase enzymes, and to elucidate their mecha-
nism of action.
We do not know whether there are additional residues of pal-
mitate bound to p55 in a stable manner that could be responsible
for performing the anchoring function to lipid rafts. The answer
to this question, which can be posed also for other potentially
palmitoylated proteins, would entail changing the experimental
approach from that based on palmitate turnover to one which directly
assays the bound fatty acid, for example after pulling down the proteins
of interest with suitable procedures, followed by proteomic/MS
analysis.
In summary, we have presented here for the ﬁrst time the exper-
imental evidence for the feasibility of studying protein palmitoylation
in the erythrocyte cell model with the new click chemistry techniques
employing bio-orthogonal analogues of fatty acids. The method was
implemented to address a speciﬁc issue (the role of p55 palmitoylation
for anchoring the lipid rafts to the membrane skeleton), but it is open to
further investigation on the still unresolved role of protein palmitoylation
in erythrocytes. Work is in progress in our laboratory to study p55 and
other palmitoylated proteins in erythrocytes of different age. Erythrocytes
contain all themachinery necessary for acylating anddeacylating selected
protein species in themembrane. In fact, not only p55, but also a number
of other important integral and peripheral proteins are reversibly
palmitoylated. It is unlikely that this is simply the vestige of a machinery
that operated in thematuration of erythroid precursors, but the discovery
of a possible functional role in the mature erythrocyte awaits future
investigations.
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